Placement Announced
JATT II Acquisition Corp placement
US$225m raised
Announced 29 Jun 2026 · NASDAQ: JATT · US$10.00 per share
Advisers
JATT II Acquisition Corp
Issuer
Not disclosed
Lead managers
- Legal adviser
- Placement agent
- Issuer
- JATT II Acquisition Corp
- Sector
- Biotech
- Tags
- Biotech, Drug Development
Similar deals
- Slate Medicines placement Aug 2026 · US$245m · Biotech
- Avenzo Therapeutics placement Jun 2026 · US$215m · Biotech
- Processa Pharmaceuticals placement Jul 2026 · US$200m · Biotech
- Agomab Therapeutics NV IPO Feb 2026 · US$200m · Biotech
- Silence Therapeutics placement Aug 2026 · US$201m · Biotech

